About the Program
Calendar 2018
Calendar 2017
Calendar 2016
Calendar 2015
Calendar 2014
Calendar 2013
Calendar 2012
Calendar 2011
The Students
Research and Faculty
Coordinating Committee
Module Coordinators
PhD Degrees Completed
Events and Highlights
All Time GABBAs
Reserved Area
Forgot your password?

The research carried out by Rosa Barreira da Silva (a former GABBA student currently working with Matthew Albert at the Institut Pasteur) provided strategies to increase the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.

Rosa Barreira da Silva and her colleagues employed means to inhibit the activity of dipeptidylpeptidase 4 (DPP4), an enzyme that degrades small molecules called chemokines, important to induce the cell migration. The authors showed that oral administration of a specific DPP4 inhibitor (sitagliptin) slows the development of several types of cancer in mice, restoring naturally occurring tumor immunity. In addition, the authors demonstrated that DPP4 inhibition prevented the degradation of the chemokine CXCL10, increasing the infiltration of T lymphocytes into tumors; and that the combination of this innovative treatment with existing immunotherapies (such as checkpoint blockade) eradicated the tumor.

Rosa Barreira da Silva is a postdoctoral researcher at the Laboratory of Dendritic Cell Immunobiology, a mixed Pasteur/Inserm unit headed by Matthew Albert at the Institut Pasteur, Paris, France. This project has received funding from the Pasteur-Roux grant, the French Cancer League (Ligue Contre le Cancer), the Fondation ARC cancer research organization and the French National Research Agency (ANR) as part of the "Immuno-Onco" LabEx (Laboratories of Excellence) program. 

Original Source


Rosa Barreira da Silva,Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll & Matthew L Albert. “Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy”, Nature Immunology, doi:10.1038/ni.3201, June 15, 2015 

Link: http://www.ncbi.nlm.nih.gov/pubmed/26075911
Published in 2015-06-29 16:52:55
Program financially supported by
the National Foundation for
Science and Technology